Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Samuel W.

Samuel W. Apicelli, Bryn Mawr, PA US

Patent application numberDescriptionPublished
20100170661HEAT PIPE WITH AXIAL AND LATERAL FLEXIBILITY - A flexible heat pipe is disclosed for use with evaporator and condenser elements for removing heat from electronic components. The flexible heat pipe comprises a bellows member fixed at one end to a condenser member and at an opposite end to an evaporator member. A cable artery is disposed within the bellows and is fixed at one end to the evaporator, and slidingly engages the condenser at the opposite end. The bellows acts as a flexible vapor envelope, and the cable artery acts as a flexible wick for directing condensed working fluid from the condenser back to the evaporator. The sliding connection between the cable artery and the condenser allows relative axial movement, and the inherent flexibility of the cable artery allows relative lateral movement. Thus, the condenser and evaporator can move in all directions with respect to each other, which can provide desired vibration isolation of the two components.07-08-2010

Samuel W. Bartholomew, Iii, Nashville, TN US

Patent application numberDescriptionPublished
20090254371Quality Assurance Methods for Medication Therapy Management - A method for improving quality assurance methods for medication therapy management using a computer particularly adapted for a health care management or delivery organization is provided, the method including at least the steps of: providing a set of internal controls, wherein the internal controls further include a set of national guidelines and standards, as well as a qualified staff; and development by the qualified staff of a clinical rule based upon the national guidelines and standards. In other embodiments, a clinical quality assurance team further reviews the clinical rule developed by the staff. In further embodiments, a set of external controls is provided, wherein the external controls include one or more of a plurality of approved pharmacists, an external clinical advisory council, and/or an independent review board. In still further embodiments, one or more members of the set of external controls either validates the clinical rule developed by the staff, or validates a staff-developed clinical rule that was subsequently reviewed by the quality assurance team.10-08-2009
20090254372Medication Risk Assessment System - A medication risk assessment method implemented using a computer particularly adapted for a health care management or delivery organization is provided, wherein the method includes at least the steps of: providing a medication risk assessment tool to a client, wherein the medication risk assessment tool includes a questionnaire, and wherein the client maintains a relationship with a population of individuals; administering the questionnaire to the population of individuals, thereby generating questionnaire data; obtaining prescription claims data from the population of individuals; combining the questionnaire data and the prescription claims data in an electronic database, thereby generating population data; analyzing the population data according to a set of rules; ranking the analyzed data according to risk; and generating at least one report based on the ranked data.10-08-2009
20090265189Medication Therapy Review Methods - A method for population and patient-specific medication therapy review using a computer particularly adapted for a medication therapy management or health care delivery organization is provided, wherein the method includes at least the steps of: collecting patient claims data; reviewing the patient claims data for accuracy and data integrity; identifying particular characteristics sought within the patient claims data; organizing and structuring the patient claims data; establishing a set of clinical rules; transforming the set of clinical rules established into a computer language, and entering the transformed clinical rules into an electronic database; and analyzing the patient claims data by applying the clinical rules using a computer particularly adapted for a medication therapy management or health care delivery organization, thereby producing an analytical result. In further embodiments, the analytic results are used to evaluate the need for patient-level medication therapy review and, optionally, to actually conduct a patient-level medication therapy review based on the review of the analytic results.10-22-2009
20100235196Points-Based Reward Program for Improving Medication Adherence and Outcomes - The invention relates to a method and an apparatus for examining an object, particularly in terms of the surface morphology thereof. Said apparatus comprises a transportable housing which can be placed, especially by hand, above the surface segment of the object that is to be examined, and at least three light sources, the optical beam axes of which extend at a slanted angle of incidence relative to the surface segment that is to be examined. The light sources are disposed inside the housing and can illuminate the surface segment that is to be examined through an illumination aperture in the housing. The apparatus further comprises at least one light sensor for detecting the light reflected on the surface segment that is to be examined and a control and evaluation unit which is connected to the light sources and the light sensor. The light sources are arranged such that the optical beam axes thereof extend on different, non-parallel reference planes.09-16-2010
20110166877Quality Assurance Methods for Medication Therapy Management - A method for improving quality assurance methods for medication therapy management using a computer particularly adapted for a health care management or delivery organization is provided, the method including at least the steps of: providing a set of internal controls, wherein the internal controls further include a set of national guidelines and standards, as well as a qualified staff; and development by the qualified staff of a clinical rule based upon the national guidelines and standards. In other embodiments, a clinical quality assurance team further reviews the clinical rule developed by the staff. In further embodiments, a set of external controls is provided, wherein the external controls include one or more of a plurality of approved pharmacists, an external clinical advisory council, and/or an independent review board. In still further embodiments, one or more members of the set of external controls either validates the clinical rule developed by the staff, or validates a staff-developed clinical rule that was subsequently reviewed by the quality assurance team.07-07-2011
20110173025Medication Risk Assessment System - A medication risk assessment method implemented using a computer particularly adapted for a health care management or delivery organization is provided, wherein the method includes at least the steps of: providing a medication risk assessment tool to a client, wherein the medication risk assessment tool includes a questionnaire, and wherein the client maintains a relationship with a population of individuals; administering the questionnaire to the population of individuals, thereby generating questionnaire data; obtaining prescription claims data from the population of individuals; combining the questionnaire data and the prescription claims data in an electronic database, thereby generating population data; analyzing the population data according to a set of rules; ranking the analyzed data according to risk; and generating at least one report based on the ranked data.07-14-2011
20110173026Medication Therapy Review Methods - A method for population and patient-specific medication therapy review using a computer particularly adapted for a medication therapy management or health care delivery organization is provided, wherein the method includes at least the steps of: collecting patient claims data; reviewing the patient claims data for accuracy and data integrity; identifying particular characteristics sought within the patient claims data; organizing and structuring the patient claims data; establishing a set of clinical rules; transforming the set of clinical rules established into a computer language, and entering the transformed clinical rules into an electronic database; and analyzing the patient claims data by applying the clinical rules using a computer particularly adapted for a medication therapy management or health care delivery organization, thereby producing an analytical result. In further embodiments, the analytic results are used to evaluate the need for patient-level medication therapy review and, optionally, to actually conduct a patient-level medication therapy review based on the review of the analytic results.07-14-2011
20120197663Medication Risk Assessment System - A medication risk assessment method implemented using a computer particularly adapted for a health care management or delivery organization is provided, wherein the method includes at least the steps of: providing a medication risk assessment tool to a client, wherein the medication risk assessment tool includes a questionnaire, and wherein the client maintains a relationship with a population of individuals; administering the questionnaire to the population of individuals, thereby generating questionnaire data; obtaining prescription claims data from the population of individuals; combining the questionnaire data and the prescription claims data in an electronic database, thereby generating population data; analyzing the population data according to a set of rules; ranking the analyzed data according to risk; and generating at least one report based on the ranked data.08-02-2012
20120245960Points-Based Reward Program For Improving Medication Adherence and Outcomes - The invention relates to a method for improving medication adherence and outcomes. The method includes registering a patient in a predetermined manner with a web site thereby creating an associated user profile, manually entering patient medication data and patient health data associated with the user profile, automatically acquiring from a third party and then storing patient medication data and patient health data associated with the user profile and assigning a points based reward based on a comparison of at least one of the manually entered data and the automatically acquired data to a predetermined set of reward criteria parameters.09-27-2012
20120259660Quality Assurance Methods for Medication Therapy Management - A method for improving quality assurance methods for medication therapy management using a computer particularly adapted for a health care management or delivery organization is provided, the method including at least the steps of: providing a set of internal controls, wherein the internal controls further include a set of national guidelines and standards, as well as a qualified staff; and development by the qualified staff of a clinical rule based upon the national guidelines and standards. In other embodiments, a clinical quality assurance team further reviews the clinical rule developed by the staff. In further embodiments, a set of external controls is provided, wherein the external controls include one or more of a plurality of approved pharmacists, an external clinical advisory council, and/or an independent review board.10-11-2012

Patent applications by Samuel W. Bartholomew, Iii, Nashville, TN US

Samuel W. Bellamy, Iii, Bryn Mawr, PA US

Patent application numberDescriptionPublished
20110276531SYSTEM AND METHOD FOR VALIDATION OF TRANSACTION DATA - A system and a method for validation of transaction data are disclosed. A rules engine in the system and the method is used to quickly and accurately deduce whether or not a transaction is a candidate for flagging with additional identification data, and a loyalty engine is used to quickly and accurately track and manage an entity relating to a transaction. In the system and the method, through compression and optimization, separate logical rules originally built are combined into an aggregate of compressed rules shared across a plurality of validations, such that the aggregate of compressed rules in the rules engine and the loyalty engine operates in memories of computing machines hosting servers. The system creates modularity and nimbleness with an internal instancing system and a dynamic routing node to multiple active instances. The multiple active instances of the rules engine and the loyalty engine support real-time updates and thus facilitate higher uptime capacities.11-10-2011
20110276717DYNAMIC AND RECURSIVE TRANSACTION GATEWAY SYSTEM AND METHOD - A dynamic and recursive transaction gateway system and its method are disclosed. The dynamic and recursive transaction gateway system is designed to handle financial, medical, and other types of transactional information. The dynamic and recursive transaction gateway system provides intelligence for processing transactions in all phases of the system. The dynamic and recursive transaction gateway system is empowered by introducing the protocol of Level 4 Data which are supplementary data used by the decision-making engine in the system. The dynamic and recursive transaction gateway system has a capability of generating and processing tokenized data which includes tokens for predetermined numbers of transactions, tokens for predetermined periods of time, tokens for unlimited time, and chain-bound tokens shared across locations. The dynamic and recursive transaction gateway system provides a novel approach: recursive transaction processing. Through the recursive transaction processing, sub-transactions generated from an original transaction are recursively fed to the system. The sub-transactions are individually processed by the system and routed to different destination systems.11-10-2011
20120130832HOST TO CLIENT PAYMENT - A system and a method of electronic transactions are disclosed. The system and method allow a consumer mobile device to capture the identification of a point-of-sale device and to initialize a transaction from the consumer mobile device to a master host platform. The point-of-sale device captures purchase items following a typical tender process and provides the master host platform with detailed purchase information. The master host platform instantiates a transaction merger to combine the identification information and the detailed purchase information. The transaction merger links the specific consumer to the specific transaction at the specific point-of-sale device. Then, the master host platform sends an authorization request to a payment processing host. The master host platform provides a connection between clients: the consumer mobile device and the point-of-sale device, and establishes a common interface between the clients and the payment processing host.05-24-2012
20120136957PORTABLE CLIENT AND SERVER PLATFORM - A portable client and server platform system is disclosed. The present system provides the abstraction of host applications in a master host platform from clients and hosts. The abstraction allows for unique scalability and cross-platform designs for large enterprise applications. The present system allows the download of a single client application onto a client to provide expansive user functionality. The functionality of the single client application is common yet specific to requirements of the operating systems, firmware, drivers, and hardware of the clients. This architectural approach abstracts the client platforms from the host applications of the master host platform. The present system has server-side application logic and switching capabilities in the master host platform; thus, the host applications are capable of remotely controlling various client platform resources for presentation of software applications onto remote clients.05-31-2012

Samuel W. Gerritz, Guilford, CT US

Patent application numberDescriptionPublished
20110288082METHODS AND COMPOSITIONS FOR INHIBITION OF THE TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE - Compounds of Formulas I-XLIII are identified as direct inhibitors of p97 ATPase or of the degradation of a p97-dependent ubiquitin-proteasome system (UPS) substrate. Methods and compositions are disclosed for inhibiting p97 ATPase and the degradation of a p97-dependent UPS substrate, and for identifying inhibitors thereof11-24-2011

Samuel W. Glass, Iii, Lynchburg, VA US

Patent application numberDescriptionPublished
20120288049Vibrothermographic Weld Inspections - The present invention is related to a system and method of inspecting a weld. The weld to be inspected is subjected to a transient sonic excitation while the weld area is monitored using a remote infrared camera. The sonic excitation induces mechanical vibration, which causes heat generation at any cracks or other anomalies in the weld. The infrared camera detects any temperature differentials in the weld, indicating the presence of an anomaly. The system and method is particularly useful for welds in environments that are unsafe for extended human presence or that are crowded or otherwise inaccessible, such as with piping or other structural components.11-15-2012

Samuel W. Oakes Jr., Plymouth, CT US

Patent application numberDescriptionPublished
20080196151Handle Assembly For a Toilet With a Rotating Sensor Assembly - A flush actuation assembly for flushing a urinal or a toilet, the flush actuation assembly comprising a housing a sensor assembly rotatably coupled to the housing, wherein the sensor assembly detects the presence/absence of a user in a target area and transmits a flush signal based on said detecting a flushing assembly, operatively coupled to the sensor assembly, for receiving the flush signal and causing the flushing of the urinal or toilet; wherein the sensor assembly is rotatable relative to the housing for detecting the presence/absence of a user in differing target areas.08-21-2008

Samuel W. Osier, Hemet, CA US

Patent application numberDescriptionPublished
20100163049RESPIRATORY MASK - A respiratory mask includes a mask frame, a cushion and a retaining element. The retaining element is embedded within the cushion and is configured to secure the cushion to the mask frame. Forehead pads can be positioned in the mask frame and be adjustable independent of one another and with respect to the mask frame.07-01-2010

Samuel W. Putch, Houston, TX US

Patent application numberDescriptionPublished
20100127461SEAL RING AND METHOD - A seal ring 05-27-2010

Samuel W. Thomas, Iii, Boston, MA US

Patent application numberDescriptionPublished
20100112715DETECTION OF EXPLOSIVES, TOXINS, AND OTHER COMPOSITIONS - The present invention generally relates to methods for modulating the optical properties of a luminescent polymer via interaction with a species (e.g., an analyte). In some cases, the present invention provides methods for determination of an analyte by monitoring a change in an optical signal of a luminescent polymer upon exposure to an analyte. Methods of the present invention may be useful for the vapor phase detection of analytes such as explosives and toxins. The present invention also provides methods for increasing the luminescence intensity of a polymer, such as a polymer that has been photobleached, by exposing the luminescent polymer to a species such as a reducing agent.05-06-2010

Samuel W. Tolkoff, Brookline, MA US

Patent application numberDescriptionPublished
20110066216COOLING DEVICE FOR REMOVING HEAT FROM SUBCUTANEOUS LIPID-RICH CELLS - A cooling device for removing heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cooling device includes a support having a first portion and a second portion. A first cooling element having a first heat exchanging surface is located at the first portion of the support. A second cooling element having a second heat exchanging surface is located at the second portion of the support. At least one of the first and second cooling elements is movable along the support and is configured to rotate for adjusting an angle between the first and second heat exchanging surfaces.03-17-2011